Clinical Trials Directory

Trials / Completed

CompletedNCT00921934

Intravenous Vitamin C in the Treatment of Viral Infection, Especially in the Treatment of Shingles

PASCORBIN 7.5g in the Treatment of Viral Infection, Especially Varicella Zoster Infection: An Observational Cohort Study

Status
Completed
Phase
Study type
Observational
Enrollment
68 (actual)
Sponsor
Pascoe Pharmazeutische Praeparate GmbH · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Chronic viral infections induce oxidative stress that can cause a number of concomitant diseases, e.g. cardio-vascular diseases or metabolic disorders. Therefore, a sufficient treatment of oxidative stress may be of benefit for the patient to prevent further diseases. Shingles (herpes zoster infection) have been successfully treated with antioxidative substances like high-dose vitamin C for ages. Not only the acute symptoms can be diminished by high-dose vitamin C. Even long-term sequelae, like painful post-herpetic neuropathy, may be mitigated or even fully avoided.

Conditions

Timeline

Start date
2009-04-01
Primary completion
2010-12-01
Completion
2010-12-01
First posted
2009-06-17
Last updated
2017-12-21
Results posted
2012-10-26

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00921934. Inclusion in this directory is not an endorsement.

Intravenous Vitamin C in the Treatment of Viral Infection, Especially in the Treatment of Shingles (NCT00921934) · Clinical Trials Directory